EUVIMEDScopri EUVIMED
Systematische ÜbersichtStudienprotokollOpen access · CC BY 4.0

Commercial Automated Insulin Delivery Systems in Type 1 Diabetes Pregnancy: Protocol for a Mixed‐Methods Systematic Review and Meta‐Analysis of Glycaemic, Perinatal, Psychosocial and Implementation Outcomes

Jieli Li iD, Elahe Sheklabadi, Rebecca F Goldstein, Ashley H Ng iD, Helena Teede iD, Negar Naderpoor

Endocrinology, Diabetes & Metabolism · 2026-09 · 9 (5)

DOI: 10.1002/edm2.70309 ↗

At a glance

Systematische Übersicht in Endocrinology, Diabetes & Metabolism, published online on 2026-09-05. Written by Jieli Li and 5 co-authors. Institution: Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Austr…. Major MEDLINE topics: Diabetes Mellitus, Type 1, Insulin, Insulin Infusion Systems, Pregnancy in Diabetics. 32 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Commercial automated insulin delivery (AID) systems are increasingly used in pregnancies complicated by Type 1 diabetes, but the evidence is dispersed across trials, observational studies, case series and qualitative research. Existing syntheses have largely emphasised glycaemic efficacy and selected perinatal outcomes, with less attention to device platform, timing of initiation, psychosocial burden, clinician workload and implementation context.

Aims

To describe the protocol for a mixed‐methods systematic review and meta‐analysis evaluating the effectiveness, safety, feasibility, acceptability and implementation of commercial AID systems in Type 1 diabetes pregnancy.

Methods

MEDLINE, Embase, CINAHL, Scopus, Emcare, the Cochrane Library, CENTRAL and ClinicalTrials.gov will be searched from 1 January 2010, with an update search before final synthesis. Eligible evidence will include randomised and non‐randomised comparative studies, observational cohorts, case series, qualitative studies and mixed‐methods studies involving pregnant women with Type 1 diabetes using commercial AID systems, including off‐label pregnancy use. Two reviewers will independently screen, extract and appraise studies and inter‐rater agreement will be reported. Randomised and non‐randomised comparative evidence will be synthesised separately and, where studies are sufficiently comparable, meta‐analysed within study‐design and comparator strata. Quantitative outcomes will include pregnancy‐specific time in range, other continuous glucose monitoring (CGM) metrics, maternal and neonatal outcomes, diabetes‐specific adverse events, psychosocial measures, cost, resource use, feasibility, implementation and early postpartum outcomes. Qualitative evidence will be synthesised thematically and integrated with quantitative findings using a convergent segregated approach.

Discussion

The review will clarify what is known about commercial AID use in Type 1 diabetes pregnancy and identify patient‐, device‐, clinician‐ and service‐level factors relevant to implementation. Trial Registration This systematic review protocol is registered with PROSPERO: CRD420251025194

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 1InsulinInsulin Infusion SystemsPregnancy in DiabeticsHypoglycemic AgentsHumansFemalePregnancySystematic Reviews as TopicMeta-Analysis as TopicBlood GlucosePregnancy Outcome

Author keywords

Type 1 diabetesautomated insulin deliveryhybrid closed looppregnancypsychosocial outcomes

Substances

InsulinHypoglycemic AgentsBlood Glucose

Authors and institutions

  • Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
  • Diabetes and Endocrinology Unit, Monash Health, Melbourne, Victoria, Australia.

ORCID profiles: Jieli Li, Ashley H Ng, Helena Teede

Cite

APA

Li, J., Sheklabadi, E., Goldstein, R. F., Ng, A. H., Teede, H., & Naderpoor, N. (2026). Commercial Automated Insulin Delivery Systems in Type 1 Diabetes Pregnancy: Protocol for a Mixed‐Methods Systematic Review and Meta‐Analysis of Glycaemic, Perinatal, Psychosocial and Implementation Outcomes. Endocrinology, Diabetes & Metabolism, 9(5). https://doi.org/10.1002/edm2.70309

Vancouver

Li J, Sheklabadi E, Goldstein RF, Ng AH, Teede H, Naderpoor N. Commercial Automated Insulin Delivery Systems in Type 1 Diabetes Pregnancy: Protocol for a Mixed‐Methods Systematic Review and Meta‐Analysis of Glycaemic, Perinatal, Psychosocial and Implementation Outcomes. Endocrinology, Diabetes & Metabolism. 2026;9(5). doi:10.1002/edm2.70309

BibTeX
@article{Li2026,
  author = {Li, Jieli and Sheklabadi, Elahe and Goldstein, Rebecca F and Ng, Ashley H and Teede, Helena and Naderpoor, Negar},
  title = {Commercial Automated Insulin Delivery Systems in Type 1 Diabetes Pregnancy: Protocol for a Mixed‐Methods Systematic Review and Meta‐Analysis of Glycaemic, Perinatal, Psychosocial and Implementation Outcomes},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2026},
  volume = {9},
  number = {5},
  doi = {10.1002/edm2.70309}
}
Start for free →